Mitomicin C

DRUG2 trials

Sponsors

Mahidol University, Blokhin's Russian Cancer Research Center

Conditions

BCG-Unresponsive Bladder CancerChronic RhinosinusitisNon-Muscle-Invasive Bladder CancerPostoperative Nasal Synerchia

Phase 2

Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

RecruitingNCT07747740

Blokhin's Russian Cancer Research CenterNon-Muscle-Invasive Bladder Cancer, BCG-Unresponsive Bladder Cancer

Start: 2026-07-09End: 2030-12-30Target: 228Updated: 2026-08-05

Phase 3

Mitomicin C for Prevention Postoperative Endoscopic Sinus Surgery Synechia and QOL in Chronic Rhinosinusitis

CompletedNCT02106793

Mahidol UniversityChronic Rhinosinusitis, Postoperative Nasal Synerchia

Start: 2015-03-31End: 2017-12-01Updated: 2018-05-23